A promising new therapy, which has reversed multiple sclerosis-induced paralysis in mice, is being prepared for human clinical trials, with some of the funding to come from a local KiwiSaver fund.
The New Zealand Innovation Booster (NZIB), a limited partnership between Wellington-based
Want to read more? It's easy.
Choose your best value subscription option
Student
Exclusive offer for uni students studying at a New Zealand university (valued at $499).
